Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma (Q90147191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

title

Vessels That Encapsulate Tumor Clusters (VETC) Pattern Is a Predictor of Sorafenib Benefit in Patients with Hepatocellular Carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

author name string

Jian-Hong Fang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Li Xu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Li-Ru Shang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Chu-Zhi Pan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Jin Ding

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Yun-Qiang Tang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Hui Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Chu-Xing Liu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Jia-Lin Zheng

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Yao-Jun Zhang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Zhong-Guo Zhou

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Jing Xu

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Limin Zheng

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

Min-Shan Chen

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

publication date

15 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

page(s)

824-839

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

cites work

Hepatocellular carcinoma

1 reference

7 January 2021

Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis

1 reference

7 January 2021

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

7 January 2021

The antiangiogenic ceiling in hepatocellular carcinoma: does it exist and has it been reached?

1 reference

7 January 2021

Decade in review-hepatocellular carcinoma: HCC-subtypes, stratification and sorafenib

1 reference

7 January 2021

Sorafenib in advanced hepatocellular carcinoma

1 reference

7 January 2021

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

7 January 2021

In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.

1 reference

7 January 2021

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

7 January 2021

Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies

1 reference

7 January 2021

Advanced Hepatocellular Carcinoma: Pretreatment Contrast-enhanced CT Texture Parameters as Predictive Biomarkers of Survival in Patients Treated with Sorafenib

1 reference

7 January 2021

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma

1 reference

7 January 2021

Focal gains of VEGFA: candidate predictors of sorafenib response in hepatocellular carcinoma.

1 reference

7 January 2021

Human and mouse VEGFA-amplified hepatocellular carcinomas are highly sensitive to sorafenib treatment.

1 reference

7 January 2021

MicroRNAs for the Prediction of Early Response to Sorafenib Treatment in Human Hepatocellular Carcinoma

1 reference

7 January 2021

Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.

1 reference

7 January 2021

Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma

1 reference

7 January 2021

Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection

1 reference

7 January 2021

Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers

1 reference

7 January 2021

An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model

1 reference

7 January 2021

Sinusoidal tumor angiogenesis is a key component in hepatocellular carcinoma metastasis

1 reference

7 January 2021

A novel vascular pattern promotes metastasis of hepatocellular carcinoma in an epithelial-mesenchymal transition-independent manner

1 reference

7 January 2021

MicroRNAs miR-125b and miR-100 suppress metastasis of hepatocellular carcinoma by disrupting the formation of vessels that encapsulate tumour clusters.

1 reference

7 January 2021

Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer

1 reference

7 January 2021

Targeting autophagy enhances sorafenib lethality for hepatocellular carcinoma via ER stress-related apoptosis

1 reference

7 January 2021

Sorafenib Activates CD95 and Promotes Autophagy and Cell Death via Src Family Kinases in Gastrointestinal Tumor Cells

1 reference

7 January 2021

Mechanisms and regulation of endothelial VEGF receptor signalling.

1 reference

7 January 2021

Peritumoral monocytes induce cancer cell autophagy to facilitate the progression of human hepatocellular carcinoma

1 reference

7 January 2021

Inefficiencies and Patient Burdens in the Development of the Targeted Cancer Drug Sorafenib: A Systematic Review

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.30366

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30506570 AND SRC:MED&resulttype=core&format=json

11 April 2020

1 reference